DGAP-News: UMS United Medical Systems International AG / Key word(s): 9-month figures/Miscellaneous UMS United Medical Systems International AG: UMS AG reports on the first nine months of 2015 / 16 14.03.2016 / 10:00 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- UMS AG reports on the first nine months of 2015 / 16 Hamburg, 14 March 2016. UMS United Medical Systems International AG i.L. (UMS, ISIN DE 0005493654 / WKN 549365) today reported on the first nine months after the dissolution of the Company on April 30, 2015. The expenses incurred are mostly covered by the liquidation provision formed in the short fiscal year, so that a profit of EUR 21k was earned on account of interest income. Since the fiscal year was changed in connection with the dissolution of the Company, the figures on the income statement in the last published reporting period are not comparable with those for the first nine months of 2015. Earnings per share amounted to EUR 0.00, following EUR -0.21 in the last published reporting period of nine months, while cash in banks fell from EUR 16.0 million at April 30, 2015 to EUR 15.5 million, as planned. Equity capital stood at EUR 15.0 million, down from EUR 14.9 million at the beginning of the fiscal year, with the equity ratio amounting to 94%. The complete report on the first nine months can be downloaded from the Company's website at www.umsag.com. About UMS International AG UMS International AG is a corporation listed in the Prime Standard segment of Deutsche Börse AG. The Company sold its interest in United Medical Systems (DE), Inc. and thus essentially all its assets on August 14, 2014. The shareholders agreed to this sale at the special meeting held on September 25, 2014. The agreement was consummated on November 11, 2014. Now that the assets have been sold, the purpose of the Company is to manage its own assets. At the shareholders meeting on April 27, 2015, the shareholders resolved to dissolve the company as of April 30, 2015. The next step will be the liquidation phase, at the end of which (probably in the summer of 2016), the remaining liquidity will be distributed to the shareholders. Contact: Christian Möller, Tel: (040) 50 01 77-00, Fax: (040) 50 01 77-77, E-Mail: [email protected] --------------------------------------------------------------------------- 14.03.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: UMS United Medical Systems International AG Borsteler Chaussee 53 22453 Hamburg Germany Phone: +49 (0)40 - 500 177 - 00 Fax: +49 (0)40 - 500 177 - 77 E-mail: [email protected] Internet: www.umsag.com ISIN: DE0005493654 WKN: 549365 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart End of News DGAP News Service --------------------------------------------------------------------------- 444707 14.03.2016